Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation

Chang Shang-Hung; Chou I-Jun; Yeh Yung-Hsin; Chiou Meng-Jiun; Wen Ming-Shien; Kuo Chi-Tai; See Lai-Chu; Kuo Chang-Fu

首页> 外文期刊>JAMA: the Journal of the American Medical Association >Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation

【24h】

Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation

机译：使用非维生素K口腔抗凝血剂与非同时药物的抗凝血剂之间的关联和非衰弱性心房颤动的主要出血的风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

IMPORTANCE Non-vitamin (oral anticoagulants (NOACs) are commonly prescribed with other medications that share metabolic pathways that may increase major bleeding risk.

机译：重要性非维生素（口服抗凝血剂（NOACS）通常用其他药物分享可能增加主要出血风险的代谢途径。

著录项

来源
《JAMA: the Journal of the American Medical Association》 |2017年第13期|共10页
作者
Chang Shang-Hung; Chou I-Jun; Yeh Yung-Hsin; Chiou Meng-Jiun; Wen Ming-Shien; Kuo Chi-Tai; See Lai-Chu; Kuo Chang-Fu;
展开▼
作者单位

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Univ Sch Med Taoyuan Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Mem Hosp Ctr Big Data Analyt &

Stat Taoyuan Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Mem Hosp Cardiovasc Dept Taoyuan Taiwan;

Chang Gung Univ Coll Med Dept Publ Hlth Taoyuan Taiwan;

Chang Gung Mem Hosp Ctr Big Data Analyt &

Stat Taoyuan Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
入库时间 2022-08-19 19:22:10

相似文献

外文文献
中文文献
专利

1. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation (vol 318, pg 1250, 2017) [J] . Chang S. H., Chou I. J., Yeh Y. H. JAMA: the Journal of the American Medical Association . 2018,第8期

机译：使用非维生素K口腔抗凝血剂之间的关联和没有同时用药的抗刺激剂和非衰弱性心房颤动的主要出血的风险（Vol 318，PG 1250,2017）
2. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]) [J] . Steinberg Benjamin A., Simon DaJuanicia N., Thomas Laine, The American Journal of Cardiology . 2017,第10期

机译：用非维生素K拮抗剂口服抗凝剂治疗心房颤动患者重大出血的管理与临床实践中的华法林（来自结果登记处的II期，用于更好地了解心房颤动的信息[轨道-AF II]）
3. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis [J] . Oh Young Bang, Young Keun On, Myung-Yong Lee, PLoS One . 2020,第11期

机译：与Warfarin相比，用非维生素K口腔抗凝剂治疗的非瓣膜心房颤动患者中风/全身栓塞和亚洲患者的主要出血的风险：来自现实世界分析的结果
4. What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation? [C] . R. CAZZIN, P. SERRA, C. FUSILLI International Workshop on Cardiac Arrhythmias . 2004

机译：在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis [O] . Oh Young Bang, Young Keun On, Myung-Yong Lee, 2020

机译：亚洲患者中风/全身栓塞和主要出血的风险与非维生素K口服抗凝血治疗的非瓣膜心房颤动与华法林相比：现实世界数据分析的结果
7. CHADS2 risk score and rate of stroke or systemic embolism and major bleeding in patients with non-valvular atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants. [O] . Van Mieghem, Walter, Lancellotti, Patrizio 2017

机译：非维生素K拮抗剂口服抗凝药治疗非瓣膜性房颤患者的CHADS2风险评分，中风或全身性栓塞和严重出血的发生率。

Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation

摘要

著录项

相似文献

相关主题

期刊订阅